首页> 外文期刊>Molecular pharmaceutics >Determination of Solid State Characteristics of Spray-Congealed Ibuprofen Solid Lipid Microparticles and Their Impact on Sustaining Drug Release
【24h】

Determination of Solid State Characteristics of Spray-Congealed Ibuprofen Solid Lipid Microparticles and Their Impact on Sustaining Drug Release

机译:喷雾凝结的布洛芬固体脂质微粒的固态特性测定及其对维持药物释放的影响

获取原文
获取原文并翻译 | 示例
           

摘要

This study was used to find solid state characteristics of ibuprofen loaded spray-congealed solid lipid microparticles (SLMs) by employing simple lipids as matrices, with or without polymeric additives, and the impact of solid drug matrix miscibility on sustaining drug release. Solid miscibility of ibuprofen with two lipids, cetyl alcohol (CA) and stearic acid (SA), were investigated using differential scanning calorimetry (DSC). SLMs containing 20% w/w ibuprofen with or without polymeric additives, PVP/VA and EC, were produced by spray congealing, and the resultant microparticles were subjected to visual examination by scanning electron microscopy (SEM), thermal analysis using DSC, and hot-stage microscopy. Intermolecular interactions between lipids and drug as well as additives were investigated by Fourier-transformed infrared spectroscopy (FTIR) and nuclear magnetic resonance spectroscopy (NMR). X-ray diffractometry (XRD) was utilized to study polymorphic changes of drug and matrix over the course of a year. Ibuprofen was found to depress the melting points of CA and SA in a colligative manner, reaching maximum solubility at 10% w/w and 30% w/w for CA and SA, respectively. Drug encapsulation efficiencies and yields of spray-congealed SLMs containing 20% w/w ibuprofen were consistently high for both lipid matrices. CA and SA were found to adopt their stable gamma- and beta-polymorphs, respectively, immediately after spray congealing. The spray congealing process resulted in ibuprofen adopting an amorphous or poorly crystalline state, with no further changes over the course of a year. SEM, DSC, and hot stage microscope studies on the SLMs confirmed the formation of a solid dispersion between ibuprofen and CA and a solid solution between ibuprofen and SA. SA was found to sustain the release of ibuprofen significantly better than CA. PVP/VA and EC showed some interactions with CA, which led to an expansion of unit cell dimensions of CA upon spray congealing, whereas they showed negligible interactions with SA. PVP/VA and EC both hastened drug release in both CA and SA matrices, despite PVP/VA being hydrophilic and EC being hydrophobic. CA and SA are useful as lipid matrices that do not exhibit polymorphism when spray-congealed. Sustained release of ibuprofen was achieved with the formation of a solid solution with SA. Solid miscibility of drug in lipid matrix has a large impact on the ability of the SLMs to sustain the release of a drug. Polymeric additives generally disrupted structural integrity of SLMs and led to faster drug release.
机译:这项研究用于通过使用简单脂质作为基质(有或没有聚合物添加剂)来确定布洛芬负载的喷雾凝结的固体脂质微粒(SLM)的固态特性,以及固体药物基质混溶性对维持药物释放的影响。使用差示扫描量热法(DSC)研究了布洛芬与两种脂质的鲸蜡醇(CA)和硬脂酸(SA)的固体混溶性。通过喷雾凝结制备含有20%w / w布洛芬的SLM(有或没有聚合物添加剂,PVP / VA和EC),然后通过扫描电子显微镜(SEM),DSC热分析和热分析所得微粒阶段显微镜。通过傅里叶变换红外光谱(FTIR)和核磁共振光谱(NMR)研究了脂质与药物以及添加剂之间的分子间相互作用。 X射线衍射仪(XRD)用于研究一年中药物和基质的多态性变化。已发现布洛芬可通过合模方式降低CA和SA的熔点,CA和SA的最大溶解度分别为10%w / w和30%w / w。对于两种脂质基质,包含20%w / w布洛芬的喷雾凝结SLM的药物封装效率和收率始终很高。发现CA和SA在喷雾凝结后立即分别采用其稳定的gamma和beta多晶型物。喷雾凝结过程导致布洛芬呈无定形或结晶度差的状态,一年之内没有进一步变化。对SLM的SEM,DSC和热台显微镜研究证实,布洛芬和CA之间形成固体分散体,布洛芬和SA之间形成固溶体。发现SA比布洛芬更好地维持布洛芬的释放。 PVP / VA和EC显示出与CA的某些相互作用,这导致喷雾凝结后CA的晶胞尺寸扩大,而与SA的相互作用可忽略不计。尽管PVP / VA是亲水性的,而EC是疏水性的,但PVP / VA和EC都加快了CA和SA基质中的药物释放。 CA和SA可用作脂质基质,在喷雾凝结时不会表现出多态性。布洛芬的持续释放是通过与SA形成固溶体来实现的。药物在脂质基质中的固体混溶性对SLM维持药物释放的能力有很大影响。聚合物添加剂通常会破坏SLM的结构完整性,并导致更快的药物释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号